The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer

Genes Chromosomes and Cancer

Volumn 52, Issue 12, 2013, Pages 1133-1140

  Wu, Weiyun ^a   Yang, Pengchun ^a   Feng, Xiao ^a   Wang, Hao ^a   Qiu, Yumei ^a   Tian, Ting ^a   He, Yanting ^a   Yu, Caiyuan ^a   Yang, Jingfang ^a   Ye, Shicai ^a   Zhou, Yu ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 32; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADENOMA; AGED; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROFILAMENT PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84886254861     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22108     Document Type: Article

References (41)

1. Baranwal S, Alahari SK. 2010. miRNA control of tumor cell invasion and metastasis. Int J Cancer 126:1283-1290.
2. Bartel DP. 2004. MicroRNAs: Genonlies, biogenesis, mechanism, and function. Cell 116:281-297.
3. Borel F, Konstantinova P, Jansen PL. 2012. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepato 56:1371-1383.
4. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. 2011. MicroRNA in prostate, bladder, and kidney cancer: A systematic review. Eur Urol 59:671-681.
5. Chen Y, Stallings RL. 2007. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67:976-983
6. Cho WC. 2007. OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 6:60.
7. Cinti C, Vindigni C, Zamparelli A, La Sala D, Epistolato MC, Marrelli D, Cevenini G, Tosi P. 2008. Activated Akt as an indicator of prognosis in gastric cancer. Virchows Arch 453:449-455.
8. Colakoglu T, Yildirim S, Kayaselcuk F, Nursal TZ, Ezer A, Noyan T, Karakayali H, Haberal M. 2008. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: Is PTEN loss predictor of local recurrence? Am J Surg 195:719-725
9. Croce CM. 2008. Oncogenes and cancer. N Engl J Med 358:502-511
10. Dicuonzo G, Angeletti S, Garcia-Foncillas J, Brugarolas A, Okrouzhnov Y, Santini D, Tonini G, Lorino G, De Cesaris M, Baldi A. 2001. Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res 7:4049-4053.
11. Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, Yung WK, Steck PA. 1999. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59:2551-2556.
12. Edge SB, Sobin LH, Page DL, Gospodarowicz MK, Greene FL, Winchester DP. 2005. Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 97:463-465.
13. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
14. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
15. Gocek E, Wang X, Liu X, Liu CG, Studzinski GP. 2011. MicroRNA-32 upregulation by 1, 25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res 71:6230-6239.
16. Hsu CP, Kao TY, Chang WL, Nieh S, Wang HL, Chung YC. 2011. Clinical significance of tumor suppressor PTEN in colorectal carcinoma. EJSO 37:140-147.
17. Hurst DR, Edmonds MD, Welch DR. 2009. Metastamir: The field of metastasis-regulatory microRNA is spreading. Cancer Res 69:7495-7498.
18. Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T. 2012. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene 31:4460-4471.
19. Jiang J, Sun X, Wang W, Jin X, Bo X, Li Z, Bian A, Jiu J, Wang X, Liu D, Hui X, Wang Y, Wang A, Ding L. 2012. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 29:3472-3477.
20. Kent OA, Mendell JT. 2006. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188-6196.
21. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. 2007. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046-1054.
22. Lei H, Zou D, Li Z, Luo M, Dong L, Wang B, Yin H, Ma Y, Liu C, Wang F, Zhang J, Yu J, Li Y. 2013. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation. PLoS One 8:e60369.
23. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M. 2011. MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol. [Epub ahead of print]
24. Li J, Du L, Yang Y, Wang C, Liu H, Wang L, Zhang X, Li W, Zheng G, Dong Z. 2013. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329:84-90.
25. Li X, Luo F, Li Q, Xu M, Feng D, Zhang G, Wu W. 2011. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol Rep 26:1431-1439.
26. Lin MS, Huang JX, Chen WC, Zhang BF, Fang J, Zhou Q, Hu Y, Gao HJ. 2011. Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology. Oncol Lett 2:1219-1224.
27. Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Ishii H, Doki Y, Mori M. 2012. microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep 28:2221-2226.
28. Palomero T, Dominguez M, Ferrando AA. 2008. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 7:965-970.
29. Pappas G, Zumstein LA, Munshi A, Hobbs M, Meyn RE. 2007. Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity. Cancer Gene Ther 14:543-549.
30. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. 2009. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35:109-114
31. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, Subramanian S, Wang L, Smyrk TC, Rodrigues CM, Thibodeau SN. 2009. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9:401.
32. Takahashi M, Cuatrecasas M, Balaguer F, Hur K, Toiyama Y, Castells A, Boland CR, Goel A. 2012. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One 7:e46684.
33. Tong AW, Nemunaitis J. 2008. Modulation of miRNA activity in human cancer: A new paradigm for cancer gene therapy? Cancer Gene Ther 15:341-355.
34. van den Berg A, Mols J, Han J. 2008. RISC-target interaction: Cleavage and translational suppression. Biochim Biophys Acta 1779:668-677.
35. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS 103:2257-2261.
36. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X. 2012. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7:e44398.
37. Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y. 2013. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 12:30.
38. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. 2011. MicroRNA in colorectal cancer: From benchtop to bedside. Carcinogenesis 32:247-253.
39. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, Li D, Zhong J. 2009. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400:97-102.
40. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198.
41. Ye J, Wu X, Wu D, Wu P, Ni C, Zhang Z, Chen Z, Qiu F, Xu J, Huang J. 2013. miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer. PLoS One 8:e60687.